News at MC3

Distribution Agreement with Medtronic Inc.

November 16, 2016
MC3 Cardiopulmonary announced today a distribution agreement with Medtronic, giving the global healthcare company exclusive worldwide distribution rights to MC3’s Soft-Flow arterial cannula globally. The partnership will mean the return to market of the world’s first diffusion tip arterial cannula, which enables caregivers to provide gentle perfusion of the aorta during cardiopulmonary bypass procedures. “Soft-Flow was once the top-selling arterial cannula in the United States and it remains a favorite among surgeons and perfusionists nationwide. We are very pleased to have this opportunity to partner with Medtronic to bring Soft-Flow to the global market,” said Scott Merz, President and CEO of MC3 Cardiopulmonary. “Medtronic’s established depth in the cardiovascular market will help ensure outstanding product distribution and support for a surgical community ready to put this important cannula product into use.” Soft-Flow, the first product launch for MC3 Cardiopulmonary, is expected to be followed by a portfolio of new products designed to support patients with cardiopulmonary dysfunction. This aligns with MC3’s mission to serve the global community by creating life restoring medical devices that address acute and chronic unmet cardiopulmonary clinical needs.
Download PDF

MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems

November 4, 2015
Company builds state-of-the-art 60,000-square-foot manufacturing facility on its 10 acre campus in Dexter, Michigan with the goal of bringing back the Sarns™ Soft-Flow® Arterial Cannula during the first half of 2016 MC3 Cardiopulmonary today announced it has completed the acquisition and transfer of all assets associated with Terumo Cardiovascular’s previously marketed Surgical Cannula line, including leading brand names like Sarns™ Soft-Flow® Arterial Cannula. Founded in 1991, as a spinout of the University of Michigan, MC3 is well known within the medical community as a pioneer in heart/lung extracorporeal life support research. The acquisition marks a major milestone in the Company’s goal to transform into a global cardiopulmonary medical device manufacturer. “This is a significant milestone for us, and we are excited to return the legacy of Soft-Flow® Arterial Cannula to the users and patients it will serve,” said Scott Merz, CEO of MC3 Cardiopulmonary. “In order to support our goals as a global medical device company, we have built a world-class facility just outside of Ann Arbor in Dexter, Michigan. The location provides close proximity to the University of Michigan, Detroit International Airport and skilled knowhow within our sector.” The Terumo Surgical Cannula was once one of the largest cardiac surgery cannula lines in the world, offering more than 200 product SKUs. The flagship product, the Soft-Flow® Arterial Cannula was the world’s first dispersion tip aortic cannula and remains a favorite among clinical users worldwide.
Download PDF

© 2018 MC3 Cardiopulmonary